Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus

References

• MacNeeWIs chronic obstructive pulmonary disease an accelerated aging disease?Ann Am Thorac Soc201613Supplement_5S429S43728005421
   PubMed Web of Science ®Google Scholar
• Department of Noncommunicable Disease Prevention and Health Promotion, WHOActive Ageing – A Policy FrameworkGenevaWHO200259
   Google Scholar
• RoglianiPLucàGLauroDChronic obstructive pulmonary disease and diabetesCOPD Res Prac201513
   Google Scholar
• FanerRSobradilloPNogueraAThe inflammasome pathway in stable COPD and acute exacerbationsERJ Open Res20162300002201627730204
   PubMedGoogle Scholar
• AgustíACalverleyPMDecramerMStockleyRAWedzichaJAPrevention of exacerbations in chronic obstructive pulmonary disease: knowns and unknownsChronic Obstr Pulm Dis20141216618428848819
   PubMedGoogle Scholar
• WedzichaJACalverleyPMRabeKFRoflumilast: a review of its use in the treatment of COPDInt J Chron Obstruct Pulmon Dis201611819026792988
   PubMed Web of Science ®Google Scholar
• RahmanIPharmacological antioxidant strategies as therapeutic interventions for COPDBiochim Biophys Acta20121822571472822101076
   PubMed Web of Science ®Google Scholar
• PoolePChongJCatesCJMucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary diseaseCochrane Database Syst Rev20157CD00128726222376
   PubMed Web of Science ®Google Scholar
• PryorRCabreiroFRepurposing metformin: an old drug with new tricks in its binding pocketsBiochem J2015471330732226475449
   PubMed Web of Science ®Google Scholar
• ItoKColleyTMercadoNGeroprotectors as a novel therapeutic strategy for COPD, an accelerating aging diseaseInt J Chron Obstruct Pulmon Dis2012764165223055713
   PubMed Web of Science ®Google Scholar
• CameronARMorrisonVLLevinDAnti-inflammatory effects of metformin irrespective of diabetes statusCirc Res2016119565266527418629
   PubMed Web of Science ®Google Scholar
• HyunBShinSLeeAMetformin down-regulates TNF-α secretion via suppression of scavenger receptors in macrophagesImmune Netw201313412313224009539
   PubMedGoogle Scholar
• CalixtoMCLintomenLAndréDMMetformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in micePLoS One2013810e7678624204674
   PubMed Web of Science ®Google Scholar
• ParkCSBangBRKwonHSMetformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinaseBiochem Pharmacol201284121660167023041647
   PubMed Web of Science ®Google Scholar
• SatoNTakasakaNYoshidaMMetformin attenuates lung fibrosis development via NOX4 suppressionRespir Res201617110727576730
   PubMed Web of Science ®Google Scholar
• SextonPMetcalfPKolbeJRespiratory effects of insulin sensitisation with metformin: a prospective observational studyCOPD201411213314223848509
   PubMedGoogle Scholar
• HitchingsAWArcherJRSrivastavaSABakerEHSafety of metformin in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitusCOPD2015122126131
   Google Scholar
• Research Data Assistance Center [homepage on the Internet]CMS data fileCenters for medicare and medicaid services Available from: https://www.resdac.org/cms-dataAccessed August 26, 2017
   Google Scholar
• Chronic Conditions Data Warehouse [homepage on the Internet]Condition categories Available from: https://www.ccwdata.org/web/guest/condition-categoriesAccessed August 26, 2017
   Google Scholar
• MapelDWDutroMPMartonJPWoodruffKMakeBIdentifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims dataBMC Health Serv Res2011114321345188
   PubMed Web of Science ®Google Scholar
• KuoYFGoodwinJSChenNWLwinKKBaillargeonJRajiMADiabetes mellitus care provided by nurse practitioners vs primary care physiciansJ Am Geriatr Soc201563101980198826480967
   PubMed Web of Science ®Google Scholar
• LiCYEricksonSRWuCHMetformin use and asthma outcomes among patients with concurrent asthma and diabetesRespirology20162171210121827245632
   PubMed Web of Science ®Google Scholar
• PapaEVDongXHassanMSkeletal muscle function deficits in the elderly: current perspectives on resistance trainingJ Nat Sci201731 pii: e272
   Google Scholar
• JonesSEMaddocksMKonSSSarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitationThorax201570321321825561517
   PubMed Web of Science ®Google Scholar
• SreekumarRNairKSSkeletal muscle mitochondrial dysfunction & diabetesIndian J Med Res2007125339941017496364
   PubMed Web of Science ®Google Scholar
• CostaTMCostaFMMoreiraCARabeloLMBoguszewskiCLBorbaVZSarcopenia in COPD: relationship with COPD severity and prognosisJ Bras Pneumol201541541542126578132
   PubMed Web of Science ®Google Scholar
• JornayvazFRShulmanGIRegulation of mitochondrial biogenesisEssays Biochem201047698420533901
   PubMed Web of Science ®Google Scholar
• MusiNHirshmanMFNygrenJMetformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetesDiabetes20025172074208112086935
   PubMed Web of Science ®Google Scholar
• BarcelóBPonsJFusterAIntracellular cytokine profile of T lymphocytes in patients with chronic obstructive pulmonary diseaseClin Exp Immunol2006145347447916907916
   PubMed Web of Science ®Google Scholar
• PerretJMcDonaldCApostolopoulosVElevated serum interleukin-5 levels in severe chronic obstructive pulmonary diseaseActa Biochim Biophys Sin (Shanghai)201749656056328398462
   PubMed Web of Science ®Google Scholar
• Dal NegroRWBonadimanLTurcoPPrevalence of different comorbidities in COPD patients by gender and GOLD stageMultidiscip Respir Med20151012426246895
   PubMedGoogle Scholar
• BlasiFNeriLCentanniSFalconeFDi MariaGClinical characterization and treatment patterns for the frequent exacerbator phenotype in chronic obstructive pulmonary disease with severe or very severe airflow limitationCOPD2017141152227824270
   PubMedGoogle Scholar
• CavaillèsABrinchault-RabinGDixmierAComorbidities of COPDEur Respir Rev20132213045447524293462
   PubMedGoogle Scholar
• CrowleyMJDiamantidisCJMcDuffieJRClinical outcomes of metformin use in populations with chronic kidney disease, congestive heart failure, or chronic liver disease: a systematic reviewAnn Intern Med2017166319120028055049
   PubMed Web of Science ®Google Scholar
• HitchingsAWLaiDJonesPWBakerEHMetformin in COPD Trial TeamMetformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trialThorax201671758759326917577
   PubMed Web of Science ®Google Scholar